HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study.

AbstractAIMS:
The aim of the present study was to investigate whether the addition of carvedilol to conventional therapy in dilated cardiomyopathy patients is associated with further benefits in the treatment of complex non-sustained ventricular arrhythmias (Lown class III, IV or V).
METHODS AND RESULTS:
We recruited 168 patients with ischaemic or idiopathic dilated cardiomyopathy, with complex ventricular arrhythmias. Patients able to tolerate low doses of carvedilol were randomized to treatment with carvedilol or placebo for 6 months. Carvedilol treatment improved ventricular function and reduced the incidence of arrhythmic episodes. Notably, by the end of the first month of treatment, the antiarrhythmic efficacy of the drug was significantly greater in patients with ischaemic than in those with idiopathic dilated cardiomyopathy, an effect that could probably be attributed to the anti-ischaemic properties of carvedilol. After 3 months, at a time when ejection fraction was significantly improved in all treated patients, the antiarrhythmic efficacy of carvedilol was similar in the two study groups.
CONCLUSIONS:
Carvedilol antiarrhythmic efficacy was paralleled by the improvement in ejection fraction, independent of the aetiology of heart failure. The possibility of adding to an already 'optimized' conventional therapy a drug able to reduce the incidence of complex non-sustained ventricular arrhythmias is a therapeutic option that should be considered in the treatment of these patients.
AuthorsG Cice, E Tagliamonte, L Ferrara, A Iacono
JournalEuropean heart journal (Eur Heart J) Vol. 21 Issue 15 Pg. 1259-64 (Aug 2000) ISSN: 0195-668X [Print] England
PMID10924316 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
CopyrightCopyright 2000 The European Society of Cardiology.
Chemical References
  • Adrenergic beta-Antagonists
  • Carbazoles
  • Propanolamines
  • Carvedilol
Topics
  • Administration, Oral
  • Adrenergic beta-Antagonists (administration & dosage)
  • Carbazoles (administration & dosage)
  • Cardiomyopathy, Dilated (complications, diagnostic imaging, drug therapy, physiopathology)
  • Carvedilol
  • Double-Blind Method
  • Echocardiography, Doppler
  • Electrocardiography, Ambulatory
  • Female
  • Heart Rate (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Propanolamines (administration & dosage)
  • Stroke Volume (drug effects)
  • Tachycardia, Ventricular (complications, diagnostic imaging, drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: